Nanosensors Detect Pancreatic Cancer in Blood Tests
2025-02-13
Researchers have developed a groundbreaking blood test using nanosensors to detect pancreatic cancer early. The test focuses on identifying active proteases, enzymes present even in the earliest stages of tumors. In a study of 356 individuals, the nanosensors achieved 98% accuracy in identifying healthy individuals and 73% accuracy in detecting pancreatic cancer, distinguishing it from other pancreatic diseases. This advance holds immense promise for improving early detection and treatment of pancreatic cancer, offering a lifeline to millions.